Switch to:
More From Other Websites
Novo Nordisk's Victoza Recommended for Label Expansion Nov 24 2014
Changes in Novo Nordisk's Executive Management Nov 24 2014
Share repurchase programme Nov 24 2014
Sanofi Shakes Off Patent Losses Nov 24 2014
Victoza® receives positive CHMP opinion for use in adults with type 2 diabetes and moderate renal... Nov 21 2014
Sanofi's Bullish Pipeline Forecast Underwhelms Street Nov 20 2014
Share repurchase programme Nov 17 2014
Novo Nordisk second best in the world at providing access to medicine Nov 17 2014
Media Release - Top 100 Employer Nov 04 2014
New phase 3a data demonstrate that 9 out of 10 adults with obesity lost weight with liraglutide 3 mg... Nov 04 2014
Novo Nordisk's Earnings Rise in Q3, 2014 Outlook Narrowed Nov 03 2014
Novo Nordisk and Roche Diabetes Care launch new treatment option to simplify insulin pump therapy Nov 03 2014
Novo Nordisk: City of Houston and Novo Nordisk partner to lead fight against urban diabetes epidemic Nov 03 2014
Trading in Novo Nordisk shares by board members, executives and associated persons on 30 October... Oct 31 2014
Novo Nordisk invests DKK 750 million in new laboratories for diabetes research in Denmark Oct 31 2014
Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% Oct 31 2014
Market Thorns, Roses, All Time Highs, and ETF All Time Highs... Oct 30 2014
Sanofi Beats on Q3 Earnings but Lantus Outlook Disappoints Oct 30 2014
Alcatel-Lucent rallies, Lufthansa slides: Europe’s big stock movers Oct 30 2014
European stocks climb for third straight day Oct 30 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

ReplyGintaras58 - 8 months ago
few excellent prducts to come soon

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial